Role of hypoxia-inducible factor-α in hepatitis-B-virus X protein-mediated MDR1 activation
- 1 June 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 357 (2) , 567-573
- https://doi.org/10.1016/j.bbrc.2007.04.012
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of hepatitis B virus X protein on the development of liver cancerJournal of Laboratory and Clinical Medicine, 2006
- Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia‐inducible factor‐1αThe FASEB Journal, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday.Journal of Pharmaceutical Sciences, 1999
- Transactivation of the human MDR1 gene by hepatitis B virus X gene productJournal of Hepatology, 1998
- The Hepatitis B Virus HBx Protein Inhibits Caspase 3 ActivityJournal of Biological Chemistry, 1998
- Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts.Journal of Clinical Investigation, 1994
- Overexpression of the MDR1 Gene and P-Glycoprotein in Human Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 1992
- HBx gene of hepatitis B virus induces liver cancer in transgenic miceNature, 1991
- Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteinsNucleic Acids Research, 1990